Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Indian Markets Decline Amid Foreign Fund Outflows and Weak Services Data

Economy

|

Updated on 06 Nov 2025, 11:13 am

Whalesbook Logo

Reviewed By

Akshat Lakshkar | Whalesbook News Team

Short Description:

Indian stock markets, Sensex and Nifty, closed lower on Thursday due to significant foreign institutional investor (FII) outflows and selling pressure in key stocks like ICICI Bank. Despite domestic institutional investors (DIIs) buying, the market sentiment was dampened by a slowdown in the services sector growth in October, which expanded at its slowest pace in five months according to HSBC India's PMI data.
Indian Markets Decline Amid Foreign Fund Outflows and Weak Services Data

▶

Stocks Mentioned:

ICICI Bank
Power Grid Corporation of India

Detailed Coverage:

The benchmark BSE Sensex declined by 148.14 points, or 0.18%, to close at 83,311.01, while the 50-share NSE Nifty dipped by 87.95 points, or 0.34%, settling at 25,509.70. This marked the second consecutive day of losses for the indices.

The primary drivers for the downturn were sustained foreign institutional investor (FII) outflows, amounting to Rs 1,067.01 crore on Tuesday, and selling in blue-chip stocks, particularly ICICI Bank. However, domestic institutional investors (DIIs) provided some cushion by purchasing equities worth Rs 1,202.90 crore.

Among the Sensex constituents, Power Grid Corporation of India, Bharat Electronics, Bajaj Finance, ICICI Bank, and NTPC were the prominent laggards. Conversely, Asian Paints, Reliance Industries, Mahindra & Mahindra, and UltraTech Cement registered gains.

Compounding market sentiment, India's services sector growth witnessed its slowest expansion in five months in October. The HSBC India Services PMI Business Activity Index fell to 58.9 from 60.9 in September, indicating softer output growth due to competitive pressures and adverse weather conditions. This economic data offset earlier optimism from the inclusion of Indian companies in the MSCI Global Standard Index and positive US macroeconomic data.

Impact: This news signals increased market volatility and cautious investor sentiment due to consistent foreign selling and a softening domestic economic indicator. This could lead to potential short-term corrections and a need for investors to monitor fund flows and economic data closely. Impact Rating: 7/10

Difficult Terms: * **Sensex**: A stock market index comprising 30 well-established companies listed on the Bombay Stock Exchange (BSE), representing a broad measure of the Indian equity market. * **Nifty**: A benchmark stock market index comprising 50 of the largest Indian companies listed on the National Stock Exchange (NSE), serving as a key indicator of the Indian stock market's performance. * **Foreign Institutional Investors (FIIs)**: Investment funds based outside India that invest in Indian financial markets. Large FII outflows can exert downward pressure on stock prices. * **Domestic Institutional Investors (DIIs)**: Investment funds based within India that invest in domestic financial markets. Their buying activity can support the market. * **HSBC India Services PMI Business Activity Index**: A monthly survey measuring the economic health of India's services sector. A reading above 50 indicates expansion in activity, while a reading below 50 signifies contraction. * **MSCI Global Standard Index**: A widely followed global equity index compiled by MSCI that represents large and mid-cap stock performance across developed and emerging markets. Inclusion in this index can attract significant foreign capital flows.


Healthcare/Biotech Sector

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions


Brokerage Reports Sector

Brokerages Issue Fresh Recommendations on Top Stocks Across Sectors

Brokerages Issue Fresh Recommendations on Top Stocks Across Sectors

Brokerages Issue Fresh Recommendations on Top Stocks Across Sectors

Brokerages Issue Fresh Recommendations on Top Stocks Across Sectors